{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:20:41Z","timestamp":1768566041784,"version":"3.49.0"},"posted":{"date-parts":[[2024,5,15]]},"group-title":"Epidemiology","reference-count":99,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>This study aims to investigate the clinical course and factors associated with hospital admission and mortality among SARS-CoV-2 patients within the Nairobi Metropolitan Area. The study utilizes a multicenter retrospective cohort design, collecting clinical characteristics and laboratory parameters of hospitalized patients from March 2020 to May 2022. Data analysis includes percentages, frequencies, chi-square tests, Kaplan-Meier analysis, pairwise comparisons, and multivariate regression models. Ethical considerations are observed throughout the research process.<\/jats:p>\n                <jats:p>The study findings highlight significant associations between comorbidities, such as hypertension, and increased mortality risk due to COVID-19. Symptoms including fever, cough, dyspnea, chest pain, sore throat, and loss of smell\/taste are also identified as predictors of mortality. Abnormal laboratory parameters, such as oxygen saturation, procalcitonin, glucose levels, serum creatinine, and gamma-glutamyl transpeptidase, are associated with mortality. However, demographic factors and certain vital signs do not exhibit significant associations.<\/jats:p>\n                <jats:p>Recommendations based on this study suggest increased monitoring and management of comorbidities, early identification and management of symptoms, regular monitoring of laboratory parameters, continued research and collaboration, and implementation of preventive measures. Overall, a multidisciplinary approach involving healthcare professionals, researchers, policymakers, and the public is crucial to improve COVID-19 outcomes and reduce mortality rates. Adaptation of strategies based on emerging evidence and resource allocation is essential for effective management of the pandemic.<\/jats:p>","DOI":"10.1101\/2024.05.15.24307403","type":"posted-content","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:10:23Z","timestamp":1715814623000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-345X","authenticated-orcid":false,"given":"Augustine Gatimu","family":"Njuguna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Wanjiru","family":"Wangombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael N.","family":"Walekhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis Kiruki","family":"Kamondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024052000000691000_2024.05.15.24307403v1.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1097"},{"key":"2024052000000691000_2024.05.15.24307403v1.2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.8.686"},{"key":"2024052000000691000_2024.05.15.24307403v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"2024052000000691000_2024.05.15.24307403v1.6","unstructured":"World Health Organization. Director-General\u2019s remarks at the media briefing on 2019-nCoV on 11 February 2020. http:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Accessed on February 12, 2020)..(former 7 and 8)"},{"key":"2024052000000691000_2024.05.15.24307403v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678"},{"key":"2024052000000691000_2024.05.15.24307403v1.8","doi-asserted-by":"crossref","unstructured":"Bai Y , Yao L , Wei T , Tian F , Jin DY , Chen L , et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020.","DOI":"10.1001\/jama.2020.2565"},{"key":"2024052000000691000_2024.05.15.24307403v1.9","doi-asserted-by":"crossref","unstructured":"Wang D , Hu B , Hu C , Zhu F , Liu X , Zhang J , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020.","DOI":"10.1001\/jama.2020.1585"},{"key":"2024052000000691000_2024.05.15.24307403v1.10","doi-asserted-by":"crossref","unstructured":"Huang C , Wang Y , Li X , Ren L , Zhao J , Hu Y , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.11","doi-asserted-by":"crossref","unstructured":"Chang, Lin M , Wei L , Xie L , Zhu G , Dela Cruz CS , et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 2020.","DOI":"10.1001\/jama.2020.1623"},{"key":"2024052000000691000_2024.05.15.24307403v1.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001316"},{"key":"2024052000000691000_2024.05.15.24307403v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2003717"},{"key":"2024052000000691000_2024.05.15.24307403v1.14","doi-asserted-by":"crossref","unstructured":"Shen KL , Yang YH. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr 2020.(former 34)","DOI":"10.1007\/s12519-020-00344-6"},{"key":"2024052000000691000_2024.05.15.24307403v1.15","doi-asserted-by":"crossref","unstructured":"Chan JF-W , Yuan S , Kok K-H , To KK-W , Chu H , Yang J , et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to person transmission: a study of a family cluster. Lancet 2020.(former 35)","DOI":"10.1016\/S0140-6736(20)30154-9"},{"issue":"10","key":"2024052000000691000_2024.05.15.24307403v1.16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/acem.14104","article-title":"Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois","volume":"27","year":"2020","journal-title":"Academic Emergency Medicine"},{"key":"2024052000000691000_2024.05.15.24307403v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/SO140-6736(20)30566-3"},{"issue":"8","key":"2024052000000691000_2024.05.15.24307403v1.18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00325481.2020.1786964","article-title":"COVID-19 and comorbidities: a systematic review and meta-analysis","volume":"132","year":"2020","journal-title":"Postgraduate medicine"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.19","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(21)00151-X","article-title":"Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study","volume":"8","year":"2021","journal-title":"The Lancet HIV"},{"issue":"11","key":"2024052000000691000_2024.05.15.24307403v1.20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7196\/SAMJ.2020.v110i11.15249","article-title":"COVID-19 deaths in South Africa: 99 days since South Africa\u2019s first death","volume":"110","year":"2020","journal-title":"SAMJ: South African Medical Journal"},{"issue":"3","key":"2024052000000691000_2024.05.15.24307403v1.21","doi-asserted-by":"crossref","first-page":"e0248281","DOI":"10.1371\/journal.pone.0248281","article-title":"Outcomes of COVID-19 patients with comorbidities in southwest Nigeria","volume":"16","year":"2021","journal-title":"PloS one"},{"key":"2024052000000691000_2024.05.15.24307403v1.22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7015"},{"key":"2024052000000691000_2024.05.15.24307403v1.23","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7567"},{"key":"2024052000000691000_2024.05.15.24307403v1.24","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01557-7"},{"issue":"8","key":"2024052000000691000_2024.05.15.24307403v1.25","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/jac\/dkab093","article-title":"Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials","volume":"76","year":"2021","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"2024052000000691000_2024.05.15.24307403v1.26","doi-asserted-by":"crossref","first-page":"101115","DOI":"10.1016\/j.rmcr.2020.101115","article-title":"Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis","volume":"31","year":"2020","journal-title":"Respiratory Medicine Case Reports"},{"key":"2024052000000691000_2024.05.15.24307403v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31022-9"},{"key":"2024052000000691000_2024.05.15.24307403v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00519-0"},{"issue":"2","key":"2024052000000691000_2024.05.15.24307403v1.29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(21)00485-0","article-title":"Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial","volume":"22","year":"2022","journal-title":"The Lancet Infectious Diseases"},{"key":"2024052000000691000_2024.05.15.24307403v1.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"issue":"12","key":"2024052000000691000_2024.05.15.24307403v1.31","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/jac\/dkab321","article-title":"Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19","volume":"76","year":"2021","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"2024052000000691000_2024.05.15.24307403v1.32","first-page":"e282","article-title":"Early use of remdesivir in patients hospitalized with COVID-19 improves clinical outcomes: a retrospective observational study. Infectious Diseases in Clinical Practice (Baltimore","volume":"29","year":"2021","journal-title":"Md"},{"issue":"10","key":"2024052000000691000_2024.05.15.24307403v1.33","doi-asserted-by":"crossref","first-page":"e0258643","DOI":"10.1371\/journal.pone.0258643","article-title":"Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study","volume":"16","year":"2021","journal-title":"PloS one"},{"issue":"5","key":"2024052000000691000_2024.05.15.24307403v1.34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MCC.0000000000000869","article-title":"Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19","volume":"27","year":"2021","journal-title":"Current Opinion in Critical Care"},{"key":"2024052000000691000_2024.05.15.24307403v1.35","doi-asserted-by":"crossref","unstructured":"Hill, J. A. , Paredes, R. , Vaca, C. , Mera, J. , Webb, B. J. , Perez, G. , \u2026 & Gottlieb, R. L. (2021). Remdesivir for the treatment of high-risk non-hospitalized individuals with COVID-19: a randomized, double-blind, placebo-controlled trial. In Open forum infectious diseases (pp. S806\u2013S807).","DOI":"10.1093\/ofid\/ofab466.1642"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jiac.2021.06.010","article-title":"Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort","volume":"27","year":"2021","journal-title":"Journal of Infection and Chemotherapy"},{"key":"2024052000000691000_2024.05.15.24307403v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89405-y"},{"key":"2024052000000691000_2024.05.15.24307403v1.38","doi-asserted-by":"crossref","first-page":"107522","DOI":"10.1016\/j.intimp.2021.107522","article-title":"Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia","volume":"95","year":"2021","journal-title":"International immunopharmacology"},{"key":"2024052000000691000_2024.05.15.24307403v1.39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ijid.2020.11.008","article-title":"Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia","volume":"102","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"2024052000000691000_2024.05.15.24307403v1.40","doi-asserted-by":"crossref","first-page":"105631","DOI":"10.1016\/j.ejps.2020.105631","article-title":"Clinical outcomes and plasma concentrations of baloxavir marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial","volume":"157","year":"2021","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"19","key":"2024052000000691000_2024.05.15.24307403v1.41","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.3390\/molecules26195795","article-title":"Discovery, development, and patent trends on molnupiravir: A prospective oral treatment for COVID-19","volume":"26","year":"2021","journal-title":"Molecules"},{"key":"2024052000000691000_2024.05.15.24307403v1.42","doi-asserted-by":"crossref","unstructured":"Fischer, W. , Eron, J. J. , Holman, W. , Cohen, M. S. , Fang, L. , Szewczyk, L. J. , \u2026 & Painter, W. P. (2021). Molnupiravir, an oral antiviral treatment for COVID-19. MedRxiv.","DOI":"10.1101\/2021.06.17.21258639"},{"key":"2024052000000691000_2024.05.15.24307403v1.43","doi-asserted-by":"crossref","unstructured":"Singh, S. K. , Jain, R. , & Singh, S . (2020). Vitamin D deficiency in patients with diabetes and COVID-19 infection: Diabetes Metab. Syndr. Clin. Res. Rev.","DOI":"10.1016\/j.dsx.2020.06.071"},{"key":"2024052000000691000_2024.05.15.24307403v1.44","doi-asserted-by":"crossref","unstructured":"Zuo, Z. , Wu, T. , Pan, L. , Zuo, C. , Hu, Y. , Luo, X. , \u2026 & Deng, M. (2021). Modalities and Mechanisms of Treatment for Coronavirus. Drug Repurposing for COVID-19 Therapy.","DOI":"10.3389\/fphar.2020.583914"},{"key":"2024052000000691000_2024.05.15.24307403v1.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2035678"},{"key":"2024052000000691000_2024.05.15.24307403v1.46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136329"},{"key":"2024052000000691000_2024.05.15.24307403v1.47","doi-asserted-by":"crossref","unstructured":"Avenda\u00f1o-Sol\u00e1, C. , Ramos-Mart\u00ednez, A. , Mu\u00f1ez-Rubio, E. , Ruiz-Antor\u00e1n, B. , de Molina, R. M. , Torres, F. , \u2026 & Duarte, R. F. (2021). A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. The Journal of clinical investigation, 131(20","DOI":"10.1172\/JCI152740"},{"issue":"6","key":"2024052000000691000_2024.05.15.24307403v1.48","doi-asserted-by":"crossref","first-page":"e2225","DOI":"10.1002\/rmv.2225","article-title":"Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics","volume":"31","year":"2021","journal-title":"Reviews in medical virology"},{"key":"2024052000000691000_2024.05.15.24307403v1.49","doi-asserted-by":"crossref","unstructured":"Agarwal, A. , Mukherjee, A. , Kumar, G. , Chatterjee, P. , Bhatnagar, T. , & Malhotra, P . (2020). Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). bmj, 371.","DOI":"10.1101\/2020.09.03.20187252"},{"key":"2024052000000691000_2024.05.15.24307403v1.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.9883"},{"key":"2024052000000691000_2024.05.15.24307403v1.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.851"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.52","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial","volume":"72","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"2024052000000691000_2024.05.15.24307403v1.53","doi-asserted-by":"crossref","unstructured":"Horby, P. , Lim, W. S. , Emberson, J. R. , Mafham, M. , Bell, J. L. , Linsell, L. , \u2026 & Landray, M. J. (2020). RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19-preliminary report. N Engl J Med, 384(10.1056).","DOI":"10.1056\/NEJMoa2021436"},{"key":"2024052000000691000_2024.05.15.24307403v1.54","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200645"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.55","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1513\/AnnalsATS.202105-623LE","article-title":"Use of Corticosteroid in Persistent Post\u2013COVID-19 Interstitial Lung Disease","volume":"18","year":"2021","journal-title":"Annals of the American Thoracic Society"},{"key":"2024052000000691000_2024.05.15.24307403v1.56","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc2114907"},{"key":"2024052000000691000_2024.05.15.24307403v1.57","unstructured":"World Health Organization. (2021). Therapeutics and COVID-19: living guideline, 31 March 2021 (No. WHO\/2019-nCoV\/therapeutics\/2021.1). World Health Organization."},{"issue":"12","key":"2024052000000691000_2024.05.15.24307403v1.58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S2213-2600(21)00435-5","article-title":"Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"9","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"issue":"5","key":"2024052000000691000_2024.05.15.24307403v1.59","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jmv.27623","article-title":"The impact of neutralizing monoclonal antibodies on the outcomes of COVID-19 outpatients: A systematic review and meta-analysis of randomized controlled trials","volume":"94","year":"2022","journal-title":"Journal of medical virology"},{"key":"2024052000000691000_2024.05.15.24307403v1.60","doi-asserted-by":"crossref","unstructured":"Stroehlein, J. K. , Wallqvist, J. , Iannizzi, C. , Mikolajewska, A. , Metzendorf, M. I. , Benstoem, C. , \u2026 & Piechotta, V. (2021). Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database of Systematic Reviews, (5).","DOI":"10.1002\/14651858.CD015043"},{"key":"2024052000000691000_2024.05.15.24307403v1.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105751"},{"key":"2024052000000691000_2024.05.15.24307403v1.62","doi-asserted-by":"crossref","unstructured":"Ibrahim, S. , Lowe, J. R. , Bramante, C. T. , Shah, S. , Klatt, N. R. , Sherwood, N. , \u2026 & Ingraham, N. (2021). Metformin and Covid-19: focused review of mechanisms and current literature suggesting benefit. Frontiers in Endocrinology, 625.","DOI":"10.3389\/fendo.2021.587801"},{"key":"2024052000000691000_2024.05.15.24307403v1.63","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26498"},{"issue":"1","key":"2024052000000691000_2024.05.15.24307403v1.64","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2214-109X(21)00448-4","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial","volume":"10","year":"2022","journal-title":"The Lancet Global Health"},{"key":"2024052000000691000_2024.05.15.24307403v1.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2639-4"},{"issue":"1","key":"2024052000000691000_2024.05.15.24307403v1.66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14760584.2022.2004125","article-title":"COVID-19 vaccine equity: a health systems and policy perspective","volume":"21","year":"2022","journal-title":"Expert Review of Vaccines"},{"key":"2024052000000691000_2024.05.15.24307403v1.67","first-page":"3","article-title":"The role of vitamins on the prevention and\/or treatment of COVID-19 infection; a systematic review","volume":"17","year":"2020","journal-title":"Modern Care Journal"},{"key":"2024052000000691000_2024.05.15.24307403v1.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104743"},{"key":"2024052000000691000_2024.05.15.24307403v1.69","doi-asserted-by":"crossref","unstructured":"Khan, H. M. W. , Parikh, N. , Megala, S. M. , & Predeteanu, G. S . (2020). Unusual early recovery of a critical COVID-19 patient after administration of intravenous vitamin C. American Journal of Case Reports, 21.","DOI":"10.12659\/AJCR.925521"},{"key":"2024052000000691000_2024.05.15.24307403v1.70","first-page":"11","article-title":"The role of vitamin C as adjuvant therapy in COVID-19","volume":"12","year":"2020","journal-title":"Cureus"},{"key":"2024052000000691000_2024.05.15.24307403v1.71","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1794819"},{"issue":"5","key":"2024052000000691000_2024.05.15.24307403v1.72","first-page":"7020","article-title":"The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study","volume":"13","year":"2021","journal-title":"Aging (Albany NY"},{"key":"2024052000000691000_2024.05.15.24307403v1.73","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00900-x"},{"key":"2024052000000691000_2024.05.15.24307403v1.74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909273011303"},{"key":"2024052000000691000_2024.05.15.24307403v1.75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501173120301"},{"key":"2024052000000691000_2024.05.15.24307403v1.76","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-021-00591-x"},{"key":"2024052000000691000_2024.05.15.24307403v1.77","doi-asserted-by":"crossref","unstructured":"Smolders, J. , van den Ouweland, J. , Geven, C. , Pickkers, P. , & Kox, M. (2021). Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism-Clinical and Experimental, 115.","DOI":"10.1016\/j.metabol.2020.154434"},{"key":"2024052000000691000_2024.05.15.24307403v1.78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"issue":"11","key":"2024052000000691000_2024.05.15.24307403v1.79","first-page":"1","article-title":"Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US","volume":"180","year":"2020","journal-title":"JAMA Internal Medicine"},{"key":"2024052000000691000_2024.05.15.24307403v1.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.81","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa231"},{"key":"2024052000000691000_2024.05.15.24307403v1.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"2024052000000691000_2024.05.15.24307403v1.83","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2024052000000691000_2024.05.15.24307403v1.84","first-page":"9","article-title":"Clinical and epidemiological characteristics of patients with common and severe COVID-19","volume":"66","year":"2020","journal-title":"Clinical Laboratory"},{"key":"2024052000000691000_2024.05.15.24307403v1.85","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"2024052000000691000_2024.05.15.24307403v1.86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"2024052000000691000_2024.05.15.24307403v1.87","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.88","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1198"},{"issue":"4","key":"2024052000000691000_2024.05.15.24307403v1.89","first-page":"304","article-title":"Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): A pooled analysis","volume":"130","year":"2020","journal-title":"Polish Archives of Internal Medicine"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.90","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","year":"2020","journal-title":"Chinese Medical Journal"},{"key":"2024052000000691000_2024.05.15.24307403v1.91","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238"},{"key":"2024052000000691000_2024.05.15.24307403v1.92","doi-asserted-by":"publisher","DOI":"10.1016\/SO140-6736(20)30566-3"},{"key":"2024052000000691000_2024.05.15.24307403v1.93","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"2024052000000691000_2024.05.15.24307403v1.94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"2024052000000691000_2024.05.15.24307403v1.95","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2024052000000691000_2024.05.15.24307403v1.96","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1198"},{"issue":"9","key":"2024052000000691000_2024.05.15.24307403v1.97","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","year":"2020","journal-title":"Chinese Medical Journal"},{"key":"2024052000000691000_2024.05.15.24307403v1.98","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238"},{"key":"2024052000000691000_2024.05.15.24307403v1.99","doi-asserted-by":"publisher","DOI":"10.1016\/SO140-6736(20)30566-3"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.15.24307403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:00:55Z","timestamp":1768507255000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.05.15.24307403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":99,"URL":"https:\/\/doi.org\/10.1101\/2024.05.15.24307403","relation":{},"subject":[],"published":{"date-parts":[[2024,5,15]]},"subtype":"preprint"}}